Max Delbrück CenterFeb 28, 2023

#StemCells and #GeneTechnology against local #muscledefects, acute muscle wasting disorders, genetic #muscularDystrophy:
Start-up #MyoPax is breaking new ground to fight #RareDiseases.

#RareDiseaseDay @rarediseaseday @campusbuch
https://www.mdc-berlin.de/news/news/deep-expertise-and-bold-vision-myopax-launches-berlin

Deep expertise, and a bold vision: MyoPax launches in Berlin

MyoPax develops regenerative therapies for previously incurable muscle diseases. An interview with co-founders Prof. Simone Spuler and Dr. Verena Schöwel-Wolf, now board member and CEO respectively